About
Overview
Catalyst is a biopharmaceutical company focused on protease therapeutics to address unmet medical needs in disorders of the coagulation systems. Catalyst’s product candidates consist of the coagulation related assets marzeptacog alfa (activated) (“MarzAA”), dalcinonacog alfa (“DalcA”), and
Management Team
We have assembled an experienced leadership team including world-class scientists, advisors, and collaborators. We have established, and continue to expand, a robust
Nassim Usman, Ph.D.
President and Chief Executive Officer
Grant Blouse, Ph.D.
Chief Scientific Officer
Tom Knudsen, DVM, Ph.D.
Senior Vice President, Corporate Development
Seline Miller, CPA
Senior Vice President, Finance
Interim Chief Financial Officer & Interim Principal Accounting Officer
Board
We have assembled an experienced leadership team including world-class scientists, advisors, and collaborators. We have established, and continue to expand, a robust
Augustine Lawlor, Chairman of the Board
Managing Director, HealthCare Ventures LLC
Errol B. De Souza, Ph.D.
Executive Chairman, Bionomics Ltd.
Andrea Hunt
Chair of G&N Committee, Member of Board of Directors, Catalyst Biosciences, Inc.
Jeanne Jew
Chief Business Officer,
Geoffrey Ling, Ph.D.
Professor of Neurology and Attending Physician, Neuro Critical Care, Johns Hopkins Hospital
Sharon Tetlow
Managing Partner, Portrero Hill Advisors
Nassim Usman, Ph.D.
President and Chief Executive Officer, Catalyst Biosciences, Inc.
Eddie Williams
Member of Board of Directors, Catalyst Biosciences, Inc.